| Literature DB >> 25942435 |
Else-Marie Dalsgaard1, Mette V Skriver2, Annelli Sandbaek1, Mogens Vestergaard3.
Abstract
BACKGROUND: Both socioeconomic position (SEP) and type 2 diabetes have previously been found to be associated with mortality; however, little is known about the association between SEP, type 2 diabetes and long-term mortality when comorbidity is taken into account.Entities:
Mesh:
Year: 2015 PMID: 25942435 PMCID: PMC4420496 DOI: 10.1371/journal.pone.0124829
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of people with and without diabetes and the general population aged 40–69 years, 2001–06.
| Diabetes | % | Population | % | |
|---|---|---|---|---|
| N | 139,681 | 6 | 2,330,206 | |
| Sex | ||||
| Men | 78,209 | 56 | 1,160,649 | 49 |
| Women | 61,472 | 44 | 1,169,557 | 50 |
| Age, mean (SD) | 55.2 (8.5) | 50.7 (9.1) | ||
| Educational level | ||||
| > 15 years | 16,541 | 11 | 459,710 | 19 |
| 10–15 years | 61,081 | 43 | 1,105,783 | 47 |
| ≤ 10 years | 62,059 | 44 | 764,721 | 32 |
| Income level | ||||
| 80 percentile | 21,419 | 15 | 466,037 | 20 |
| 20–80 percentile | 84,412 | 60 | 1,398,126 | 60 |
| 20 percentile | 33,850 | 24 | 466,042 | 20 |
| Cohabitation status | ||||
| Cohabitant | 100,384 | 71 | 1,759,990 | 75 |
| Living alone | 39,297 | 28 | 570,216 | 24 |
| Death before follow-up | 19,947 | 14 | 195,198 | 8 |
| Age at death, mean (SD) | 67.0 (7.9) | 64.6 (8.8) | ||
| CVD before study start | 27,342 | 19 | 123,636 | 5 |
| Cancer before study start | 7,035 | 4 | 55,809 | 2 |
| CVD during follow-up | 40,476 | 28 | 382,715 | 16 |
| Cancer during follow-up | 17,269 | 12 | 220,498 | 9 |
| Other diseases during follow-up | 22,172 | 15 | 270,844 | 11 |
Fig 1Age-standardized mortality rates according to educational level, income level and cohabitation status among people with and without diabetes in the Danish population aged 40–69 years at inclusion, mean follow-up 9.5 years.
Red: People with diabetes, Blue: People without diabetes.
MRR for all-cause mortality among people with and without diabetes in the Danish population aged 40–69 years at inclusion, mean follow-up: 9.5 years.
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| Without diabetes | Diabetes | Without diabetes | Diabetes | Without diabetes | Diabetes | |
|
| ||||||
|
| ||||||
| > 15 years | Ref. | 2.2 (2.0,2.4) | Ref. | 2.1 (1.9,2.3) | Ref. | 2.1 (1.9,2.3) |
| 10–15 years | 1.3 (1.3,1.4) | 2.5 (2.3,2.6) | 1.3 (1.3,1.4) | 2.3 (2.1,2.5) | 1.3 (1.2,1.3) | 2.2 (2.0,2.3) |
| ≤ 10 years | 1.7 (1.6,1.7) | 2.8 (2.7,3,0) | 1.7 (1.6,1.8) | 2.7 (2.6,2.9) | 1.7 (1.6,1.8) | 2.7 (2.5,2.8) |
|
| ||||||
| 80 percentile | Ref. | 2.3 (2.1,2.5) | Ref. | 2.2 (2.0,2.3) | Ref. | 2.0 (1.9,2.2) |
| 20–80 percentile | 1.4 (1.4,1.5) | 2.7 (2.5,2.9) | 1.5 (1.4,1.6) | 2.5 (2.4,2,7) | 1.5 (1.4,1.5) | 2.5 (2.3,2.7) |
| 20 percentile | 1.7 (1.6,1.8) | 2,8 (2.6,3.0) | 1.7 (1.7,1.8) | 2.7 (2.5,2.9) | 1.8 (1.7,1.9) | 2.8 (2.6,3.0) |
|
| ||||||
| Cohabitant | Ref. | 1.9 (1.8,2.0) | Ref. | 1.8 (1.7,1.9) | Ref. | 1.8 (1.7,1.8) |
| Living alone | 1.5 (1.5,1.5) | 2.5 (2.3,2.6) | 1.5 (1.4,1.5) | 2.3 (2.2,2.4) | 1.4 (1.4,1.5) | 2.2 (2.1,2.4) |
|
| ||||||
|
| ||||||
| > 15 years | Ref. | 2.2 (2.0,2.3) | Ref. | 2.0 (1.9,2.2) | Ref. | 1.9 (1.8,2,1) |
| 10–15 years | 1.3 (1.3,1.4) | 2.5 (2.3,2.6) | 1.3 (1.3,1.4) | 2.3 (2.1,2.4) | 1.3 (1.3,1.4) | 2.15 (2.0,2.3) |
| ≤ 10 years | 1.5 (1.4,1.5) | 2.4 (2.3,2.6) | 1.5 (1.4,1.5) | 2.3 (2.2,2.4) | 1.5 (1.5,1.6) | 2.3 (2.2,2.4) |
|
| ||||||
| 80 percentile | Ref. | 2.2 (2.1,2.3) | Ref. | 2.0 (1.9,2.2) | Ref. | 1.9 (1.8,2.0) |
| 20–80 percentile | 1.5 (1.5,1.6) | 2.8 (2.6,3.0) | 1.6 (1.5,1.6) | 2.6 (2.4,2.7) | 1.5 (1.5,1.6) | 2.4 (2.3,2.6) |
| 20 percentile | 1.8 (1.8,1.9) | 2.9 (2.8,3.1) | 1.8 (1.8,1.9) | 2.7 (2.6,2.9) | 1.8 (1.8,1.9) | 2.7 (2.5,2.9) |
|
| ||||||
| Cohabitant | Ref. | 2.0 (2.0,2.1) | Ref. | 1.8 (1.8,1.9) | Ref. | 1.8 (1.7,1.9) |
| Living alone | 1.8 (1.8,1.9) | 2.7 (2.6,2.9) | 1.9 (1.8,1.9) | 2.6 (2.5,2.7) | 1.9 (1.9,2.0) | 2.6 (2.4,2.7) |
Model 1. Adjusted for age, duration of diabetes, calendar time. Model 2. Further adjusted for CVD and cancer before study start. Model 3. Further adjusted for CVD and cancer before study start and CVD, cancer and no. of other diseases according to Charlson Comorbidity Index during follow-up. Reference: Highest SEP-level among people without diabetes, Interaction between SEP and diabetic status, p<0.001